Abstract
Research is an important activity in nanobiotechnology both in the academic and commercial sectors. Major portion of the research activity is in the commercial sector and is focused on translation into clinical applications as the number of products in the market is still limited. Two important segments of research in the commercial sector are nanodiagnostics and nanoparticle-based drug delivery. Whereas most of the academic research in the US is funded by government agencies, research in the commercial sector is funded by venture capital and other private sources. Research activities at various companies involved in nanobiotechnology are described. There are numerous collaborations between the academia and the industry and many discoveries made in universities are commercialized by the companies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Committee on Triennial Review of the National Nanotechnology Initiative. Report. Washington, DC; NAS, National Academies Press; 2016.
Kharlamov AN, Tyurnina AE, Veselova VS, et al. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015;7:8003–15.
Lisziewicz J, Bakare N, Calarota SA, et al. Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals. PLoS One. 2012;7(5):e35416.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Jain, K.K. (2017). Research and Future of Nanomedicine. In: The Handbook of Nanomedicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6966-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6966-1_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6965-4
Online ISBN: 978-1-4939-6966-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)